Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
101 Pulmonary Metastasectomy for Sarcoma of Gynaecologic Origin Heart, Lung, and Circulation, April 5, 2013 Clinical Article
102 Dedifferentiated Peripheral Chondrosarcoma: A Review of Radiologic Characteristics Sarcoma, April 4, 2013 Review Article Clinical Article
103 CD34-Positive Superficial Myxofibrosarcoma: A Potential Diagnostic Pitfall Journal of Cutaneous Pathology, April 4, 2013 Review Article Clinical Article
104 High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma Cancer Research, April 2, 2013 Clinical Article
105 Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway Cancer Research, April 2, 2013 Clinical Article
106 Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib Full Text OncoTargets and Therapy, April 2, 2013 Review Article Clinical Article
107 Do Malignant Bone Tumors of the Foot Have a Different Biological Behavior than Sarcomas at Other Skeletal Sites Sarcoma, April 1, 2013 Clinical Article
108 Induction of Cell Cycle Arrest and Apoptosis in Human Osteosarcoma U-2 OS Cells by Solanum lyratum Extracts Nutrition and Cancer, March 29, 2013 Clinical Article
109 Radiation Therapy for Angiosarcoma: The 35-year University of Florida Experience American Journal of Clinical Oncology, March 29, 2013 Clinical Article
110 Dermoscopy of dermatofibrosarcoma protuberans: a study of 15 cases British Journal of Dermatology, March 28, 2013 Clinical Article
111 Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival Annals of Oncology, March 27, 2013 Review Article
112 Outcome of patients with advanced solitary fibrous tumors: the Centre Leon Berard experience Full Text BMC Cancer, March 27, 2013 Clinical Article
113 Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling Carcinogenesis, March 27, 2013 Clinical Article
114 Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics Journal of Cancer Research & Clinical Oncology, March 27, 2013 Clinical Article
115 Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets [Sarcomas] Journal of Clinical Oncology, March 27, 2013 Clinical Article
116 A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma Sarcoma, March 26, 2013 Clinical Article
117 Multiple primary malignancies in elderly patients with high-grade soft tissue sarcoma International Journal of Clinical Oncology, March 25, 2013 Clinical Article
118 Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis Tumor Biology, March 21, 2013 Clinical Article
119 Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide Full Text BMC Cancer, March 20, 2013 Clinical Article
120 Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors Cellular Oncology, March 20, 2013 Clinical Article
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summary1 Cediranib for Metastatic Alveolar Soft Part Sarcoma Journal of Clinical Oncology, May 6, 2013
2 Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Childrens Research Hospital experience Cancer, May 2, 2013
3 Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis Journal of Clinical Oncology, May 17, 2013 Review Article
4 Transcutaneous electrical nerve stimulation for treatment of sarcoma cancer pain Pain Management, May 20, 2013
5 Activity endpoints reported in soft tissue sarcoma phase II trials: quality of reported endpoints and correlation with overall survival Critical Reviews in Oncology/Hematology, May 29, 2013 Evidence Based Medicine Review Article
6 Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma Human Pathology, May 16, 2013
7 Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations American Journal of Surgical Pathology , May 15, 2013
8 Vincristine, Irinotecan, and Temozolomide for Treatment of Relapsed Alveolar Rhabdomyosarcoma Journal of Pediatric Hematology/Oncology, April 29, 2013
9 Minnelide reduces tumor burden in preclinical models of osteosarcoma Cancer Letters, May 1, 2013
10 From the radiologic pathology archives: ewing sarcoma family of tumors: radiologic-pathologic correlation RadioGraphics, May 23, 2013
11 Regulation of Target Genes of PAX3-FOXO1 in Alveolar Rhabdomyosarcoma Anticancer Research, May 14, 2013
12 Sorafenib in patients with progressive epithelioid hemangioendothelioma Cancer, April 25, 2013
13 The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab')2-R1507 fragments in Ewing sarcomas European Journal of Cancer, May 14, 2013
14 Carcinosarcoma of the liver: report of a case Surgery Today, May 13, 2013 Review Article
15 Clinical report on transarterial neoadjuvant chemotherapy of malignant fibrous histiocytoma in soft tissue Clinical and Translational Oncology, May 2, 2013 Review Article
16 High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma Cancer Research, April 2, 2013
17 Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity Cancer Immunology, Immunotherapy, April 30, 2013
18 Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma Molecular Cancer Therapeutics, May 14, 2013
19 Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma Virchows Archiv, May 22, 2013
20 ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic dna methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance Clinical Cancer Research, May 24, 2013
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close